In vitro immunomodulatory effects of pentoxifylline
- 31 August 1993
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 37 (2-3) , 131-138
- https://doi.org/10.1016/0165-2478(93)90022-t
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: A pilot studyCancer Immunology, Immunotherapy, 1993
- Pentoxifylline inhibits interleukin-2-induced toxicity in C57BL/6 mice but preserves antitumor efficacy.Journal of Clinical Investigation, 1992
- Human anti-interleukin 1α antibodiesImmunology Letters, 1991
- Pentoxifylline and other methyl xanthines inhibit interleukin-2 receptor expression in human lymphocytesCellular Immunology, 1991
- Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents.The Journal of Experimental Medicine, 1991
- Pentoxifylline inhibits actin polymerization in human neutrophils after stimulation by chemoattractant factorInflammation Research, 1990
- The effects of pentoxifylline on lipopolysaccharide (LPS) fever, plasma interleukin 6 (IL 6), and tumor necrosis factor (TNF) in the ratCytokine, 1990
- Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.The Journal of Experimental Medicine, 1990
- OXPENTIFYLLINE IN ENDOTOXAEMIAThe Lancet, 1989
- Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofyllineBiochemical and Biophysical Research Communications, 1988